Variants in IL28B in Liver Recipients and Donors Correlate With Response to Peg-Interferon and Ribavirin Therapy for Recurrent Hepatitis C
Takasuke Fukuhara(Hokkaido University), Yoshihiko Maehara(Kyushu University), Yuji Soejima(Shinshu University), Hideaki Uchiyama(Kyushu University), Akinori Ninomiya(The University of Osaka), Akinobu Taketomi(Hokkaido University), Yoshiharu Matsuura(Department of Virology), Takashi Motomura(Kyushu University), Shinji Okano, Takayuki Abe(Niigata University), Ken Shirabe(Gunma University)
Cited by 214
Related Papers
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
|Journal of Hepato-Biliary-Pancreatic Sciences|2015|267
Randomized phase <scp>III</scp> study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (<scp>KHBO1401</scp>‐ <scp>MITSUBA</scp>)
|Journal of Hepato-Biliary-Pancreatic Sciences|2022|244